Zobrazeno 1 - 10
of 77
pro vyhledávání: '"F, Wielaard"'
Autor:
P. W. A. Vermunt, J.A.M. van Oers, Caroline A. Baan, Gert P. Westert, F. Wielaard, J.H.M. de Vries, Ivon E J Milder
Publikováno v:
Diabetic Medicine. 29:e223-e231
Diabet. Med. 29, e223-e231 (2012) ABSTRACT: Aims To determine the effectiveness of a 2.5-year lifestyle intervention for Type 2 diabetes prevention in Dutch general practice compared with usual care. Methods A randomized controlled trial of 925 indiv
Autor:
H. A. M. van Oers, Ivon E J Milder, P. W. A. Vermunt, J.H.M. de Vries, Gert P. Westert, F. Wielaard
Publikováno v:
Diabetes Care
OBJECTIVE To study the overall effect of the Active Prevention in High-Risk Individuals of Diabetes Type 2 in and Around Eindhoven (APHRODITE) lifestyle intervention on type 2 diabetes risk reduction in Dutch primary care after 0.5 and 1.5 years and
Autor:
Jos D M Schelfhout, P. W. A. Vermunt, Hans van Oers, Gert P. Westert, F. Wielaard, Ivon E J Milder, Caroline A. Baan
Publikováno v:
BMC Family Practice, 14(1):78. BioMed Central
BMC Family Practice
BMC Family Practice
Background Despite the favorable effects of behavior change interventions on diabetes risk, lifestyle modification is a complicated process. In this study we therefore investigated opportunities for refining a lifestyle intervention for type 2 diabet
Autor:
Jos D M Schelfhout, P. W. A. Vermunt, F. Wielaard, Caroline A. Baan, Ivon E J Milder, Gert P. Westert, Hans van Oers
Publikováno v:
BMC Family Practice, 13:79. BioMed Central
BMC Family Practice, 13
BMC Family Practice, Vol 13, Iss 1, p 79 (2012)
BMC Family Practice
BMC Family Practice, 13
BMC Family Practice, Vol 13, Iss 1, p 79 (2012)
BMC Family Practice
Contains fulltext : 108251.pdf (Publisher’s version ) (Open Access) BACKGROUND: As in clinical practice resources may be limited compared to experimental settings, translation of evidence-based lifestyle interventions into daily life settings is ch
Publikováno v:
Family Practice, 27, 312-319. Oxford University Press
Background. Several trials have shown the potential of lifestyle intervention programmes for prevention of type 2 diabetes. The effectiveness of implementation of these programmes into daily practice is now being studied in several countries. The ‘
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee153ca05386f1a5a91557dc52994dc3
https://research.tilburguniversity.edu/en/publications/d12c3c1c-85f1-4bdb-aae2-30797d8ba0a9
https://research.tilburguniversity.edu/en/publications/d12c3c1c-85f1-4bdb-aae2-30797d8ba0a9
Autor:
J.A.M. van Oers, F. Wielaard, Gert P. Westert, P. W. A. Vermunt, Caroline A. Baan, J.D.M. Schelfhout, Ivon E J Milder
Publikováno v:
Nederlands Tijdschrift voor Diabetologie. 10:199-199
Doordat (financiele) middelen in de dagelijkse zorgpraktijk vaak beperkt zijn vergeleken met studies in een onderzoekssetting, vormt de vertaling van bewezen effectieve interventies naar de reguliere zorg een uitdaging. In deze studie evalueerden we
Publikováno v:
Journal of Virological Methods. 17:141-148
A simple one-step ELISA to detect anti-CMV antibodies was developed. The test was based on the inhibition principle, and used anti-CMV coated microtitre plates, CMV nuclear antigen and anti-CMV Fab'-HRP conjugate; total assay time was 1.5 h. The use
Autor:
H Williams, W. Duermeyer, E H van Elven, A W Joss, H. Van Gruijthuijsen, L Skinner, F. Wielaard
Publikováno v:
Journal of Clinical Microbiology. 17:981-987
A recently developed enzyme-linked immunosorbent assay for detection of immunoglobulin M (IgM) class antibodies to Toxoplasma gondii was evaluated with respect to specificity and sensitivity. By using an antibody capture principle and F(ab')2 conjuga
Publikováno v:
Journal of Medical Virology. 5:143-150
From December 1977 until April 1978 a hepatitis A outbreak occurred in an institution for the mentally retarded. The institution housed 311 residents and had a staff of 308. The outbreak was studied by enzyme-linked immunosorbent assays for hepatitis
Publikováno v:
Vox Sanguinis. 51:31-34
An anti-CMV ELISA was developed in which monoclonal antibodies to immobilize the CMV antigens are used. The test was compared with the IHA test and there was 98.6% agreement. Using the CF test as a referee, sensitivity and specificity of the ELISA we